These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7989940)

  • 1. Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer.
    Browman GP; Cripps C; Hodson DI; Eapen L; Sathya J; Levine MN
    J Clin Oncol; 1994 Dec; 12(12):2648-53. PubMed ID: 7989940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer.
    Taylor SG; Murthy AK; Vannetzel JM; Colin P; Dray M; Caldarelli DD; Shott S; Vokes E; Showel JL; Hutchinson JC
    J Clin Oncol; 1994 Feb; 12(2):385-95. PubMed ID: 8113846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol.
    Abitbol A; Abdel-Wahab M; Lewin A; Troner M; Rodrigues MA; Hamilton-Nelson KL; Markoe A
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):942-7. PubMed ID: 12095561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck.
    Garden AS; Harris J; Vokes EE; Forastiere AA; Ridge JA; Jones C; Horwitz EM; Glisson BS; Nabell L; Cooper JS; Demas W; Gore E
    J Clin Oncol; 2004 Jul; 22(14):2856-64. PubMed ID: 15254053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori H; Tsukuda M; Watai K
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer.
    Prosnitz RG; Yao B; Farrell CL; Clough R; Brizel DM
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1087-95. PubMed ID: 15752888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
    Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
    J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).
    Rivera F; Vega-Villegas ME; López-Brea M; Isla D; Mayorga M; Galdós P; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Mayordomo J; Rama J; Saiz-Bustillo R; Sanz-Ortiz J
    Cancer Chemother Pharmacol; 2008 Jul; 62(2):253-61. PubMed ID: 17901953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
    Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.
    Wendt TG; Grabenbauer GG; Rödel CM; Thiel HJ; Aydin H; Rohloff R; Wustrow TP; Iro H; Popella C; Schalhorn A
    J Clin Oncol; 1998 Apr; 16(4):1318-24. PubMed ID: 9552032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
    Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Head and Neck Radiotherapy Questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer.
    Browman GP; Levine MN; Hodson DI; Sathya J; Russell R; Skingley P; Cripps C; Eapen L; Girard A
    J Clin Oncol; 1993 May; 11(5):863-72. PubMed ID: 8487051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.
    Wibault P; Bensmaine MA; de Forni M; Armand JP; Tellez Bernal E; Guillot T; Recondo G; Domenge C; Janot F; Borel C; Luboinski B; Eschwege F; Cvitkovic E
    J Clin Oncol; 1996 Apr; 14(4):1192-200. PubMed ID: 8648374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer.
    Vokes EE; Haraf DJ; Mick R; McEvilly JM; Weichselbaum RR
    J Clin Oncol; 1994 Nov; 12(11):2351-9. PubMed ID: 7525886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).
    Ghadjar P; Simcock M; Studer G; Allal AS; Ozsahin M; Bernier J; Töpfer M; Zimmermann F; Betz M; Glanzmann C; Aebersold DM;
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):524-31. PubMed ID: 21300466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W; Hehr T; Budach V; Belka C; Dietz K
    BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant chemo/radiotherapy for advanced carcinoma of the head and neck.
    Macmillan CH; Carrick K; Bradley PJ; Morgan DA
    Br J Radiol; 1991 Oct; 64(766):941-6. PubMed ID: 1954537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma.
    Urba SG; Forastiere AA; Wolf GT; Esclamado RM; McLaughlin PW; Thornton AF
    J Clin Oncol; 1994 May; 12(5):946-53. PubMed ID: 8164046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
    J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.